FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.

FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added brain tumor warning to the label.

The MarketWatch News Department was not involved in the creation of this content. -- Global pharmaceutical company Pfizer Inc. is facing a multidistrict litigation (MDL No.3140) in the USA, currently ...

The MarketWatch News Department was not involved in the creation of this content. The number of lawsuits filed has tripled to over 1300 since May New US peer-reviewed study adds to body of research ...